Multi-center Study on Reducing Postoperative Pulmonary Complications in Elderly Patients

January 3, 2023 updated by: Wuhan Union Hospital, China

Multi-center Study on Reducing Postoperative Pulmonary Complications in Elderly Patients Based on Comprehensive Intervention System

The purpose of this study is to carry out demonstrative comprehensive intervention for elderly patients in several hospitals to observe whether it can reduce the incidence and mortality of perioperative pulmonary complications in elderly patients and improve their perioperative prognosis.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study investigated the incidence of postoperative pulmonary complications in various hospitals, and carried out demonstrative comprehensive intervention for elderly patients in several hospitals according to the comprehensive intervention system program of perioperative pulmonary complications, to observe whether the perioperative prognosis can be improved and the quality of life can be improved, thus verifying and optimizing the current evaluation system and intervention system, and providing evidence support for further extensive application.

Study Type

Interventional

Enrollment (Anticipated)

5000

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. age 65 years or older
  2. receiving invasive ventilation during general anesthesia for surgery

Exclusion Criteria:

  1. preoperative mechanical ventilation
  2. procedures related to a previous surgical complication
  3. a second operation after surgery
  4. organ transplantation
  5. discharged within 24 hours after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
No intervention
Experimental: intervention group
Application of integrated intervention system programs
Other: Application of integrated intervention system programs
Application of integrated intervention system programs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Postoperative pulmonary complications
Time Frame: within one week after surgery
within one week after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Postoperative pulmonary complications
Time Frame: 30 days after surgery
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wuhan Union Hospital, China

Collaborators

Qinghai People's Hospital
Wuhan Central Hospital
Shanxi Cardiovascular Hospital
Shiyan Taihe Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2023

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

May 1, 2023

Study Registration Dates

First Submitted

January 2, 2023

First Submitted That Met QC Criteria

January 3, 2023

First Posted (Actual)

January 5, 2023

Study Record Updates

Last Update Posted (Actual)

January 5, 2023

Last Update Submitted That Met QC Criteria

January 3, 2023

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PPC20221203

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pulmonary Complications

Clinical Trials on Application of integrated intervention system programs

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe